UCSF

Tagged: industry-sponsored research

Study shows sugar industry buried evidence of health risks

“UCSF has put its stake in the ground on exposing industry manipulation of science.”

Analysis finds sponsorship biases in animal studies may differ from those in clinical trials

A new analysis of dozens of animal studies evaluating the effects of the cholesterol-lowering statin class of drugs on atherosclerosis found larger positive effects in studies not sponsored by the pharmaceutical industry as compared to those that were industry sponsored.

New review finds drug, device study results affected by funding source

An updated and expanded review of clinical research papers on drugs and medical devices finds that industry-sponsored studies are more likely to lead to favorable results, including reports of greater benefits and fewer harmful side effects.

The Lancet profiles Lisa Bero’s “path of most resistance”

Health policy expert Lisa Bero, PhD, is hailed in the latest issue of The Lancet for tackling hot-button subjects such as financial biases in drug research.

Industry-sponsored Research More Likely to Favor Drug Than Placebo

Published results of drug trials sponsored by the pharmaceutical industry are more likely than trials not sponsored by the industry to favor drug over placebo, according to

Industry Data Should Be Shared

The same level of legal scrutiny that applies to research funded by the US government should apply to research funded by industry, according to UCSF School of Pharmacy faculty member Lisa Bero, PhD, and co-authors of a study that appeared July 20, 2005 in the online issue of American Journal of Public Health.